Search

Embracing assistive technology in the fight against sight loss

The author shares his own experience of sight loss and explains the vital role assistive technology can play in the lives of visually impaired patients. There is no doubt that sight loss continues to be a clear and present danger,...

WHO SPECS 2030: a global initiative to strengthen refractive error services

Globally, it is estimated that only around one-third of people with vision impairment due to refractive error have received access to a quality pair of spectacles [1]. In recognition that uncorrected refractive error is the leading cause of vision impairment...

Redeployment during the COVID-19 pandemic: personal accounts from four ophthalmology trainees

We once believed that the coronavirus would not penetrate the safe confines of the United Kingdom, like so many outbreaks before this. Once the news came that this pandemic descended into our hospitals, the anxieties about redeployment began. Many of...

Sustainability in eyecare: Climate action in eyecare

Climate change will cause disruption to critical eyecare services and increases in rates of eye disease around the world. The International Agency for Prevention of Blindness has recommended 10 key areas of action on how the eyecare sector can address...

Cutting-edge practice in glaucoma care: what, how and why?

More effective treatments and drug delivery modalities, implantable minimally invasive glaucoma surgical (MIGS) devices, as well as accelerating clinical research programmes, will transform the surgical and clinical management of glaucoma in the near future. There is also an ever-greater emphasis...

Eye Capacity: clinical need should drive ophthalmic service provision

Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...

My top five: Emerging alternatives to manage and treat nAMD

Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

Strengthening capacity for ophthalmic research within three East African VISION 2020 LINKS – The Research Mentorship Workshop

Building capacity for ophthalmic research in low- and middle-income countries is an important aim of the VISION 2020 LINKS Programme. The International Centre for Eye Health (ICEH) at the London School of Hygiene & Tropical Medicine (LSHTM) has been working...

Cementing a VISION 2020 LINK partnership between Blantyre and Liverpool – building capacity for DR services alongside research

Malawi is a small land-locked country in eastern Africa with a growing population of over 17 million people. About 45% of the population is aged 14 or under; only 5% are aged 60 or over. The gross national income per...

FAQs about cerebral visual impairment (CVI): identifying and helping those affected

Cerebral visual impairment is common in both adults and children, yet the diagnosis can easily be missed unless one is tuned into the presenting features. This article provides a succinct introduction to this important topic. What is vision? Vision is...